Kite Pharma Inc (KITE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -267,070 | -101,653 | -42,569 | -6,366 | -2,573 |
| Depreciation Amortization | 12,215 | 5,236 | 262 | 17 | 9 |
| Income taxes - deferred | -2,895 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,255 | 4,534 | 1,937 | 255 | 52 |
| Other Working Capital | 15,667 | 38,761 | 2,957 | 622 | -274 |
| Other Operating Activity | 70,924 | 34,090 | 20,341 | -140 | 0 |
| Operating Cash Flow | $-168,904 | $-19,032 | $-17,072 | $-5,612 | $-2,786 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -86,770 | -65,277 | -158,039 | N/A | N/A |
| PPE Investments | -20,146 | -26,573 | -2,100 | -279 | -2 |
| Net Acquisitions | N/A | -14,690 | N/A | N/A | N/A |
| Purchase Of Investment | -6,025 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-112,941 | $-106,540 | $-160,139 | $-279 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 50,000 | N/A | 250 |
| Debt Repayment | -126 | -16 | -17 | N/A | N/A |
| Common Stock Issued | 3,711 | 307,679 | 337,754 | N/A | 5 |
| Common Stock Repurchased | 2,369 | 1,405 | N/A | N/A | N/A |
| Other Financing Activity | -2,259 | 0 | -23,585 | 19,597 | 0 |
| Financing Cash Flow | $3,695 | $309,068 | $364,152 | $19,597 | $255 |
| Exchange Rate Effect | -132 | 49 | N/A | N/A | N/A |
| Beginning Cash Position | 392,843 | 209,298 | 22,357 | 8,651 | 11,184 |
| End Cash Position | 114,561 | 392,843 | 209,298 | 22,357 | 8,651 |
| Net Cash Flow | $-278,282 | $183,545 | $186,941 | $13,706 | $-2,533 |
| Free Cash Flow | |||||
| Operating Cash Flow | -168,904 | -19,032 | -17,072 | -5,612 | -2,786 |
| Capital Expenditure | -20,146 | -26,573 | -2,100 | -279 | -2 |
| Free Cash Flow | -189,050 | -45,605 | -19,172 | -5,891 | -2,788 |